This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1993;29A(3):297-8.

doi: 10.1016/0959-8049(93)90369-q.

The real costs of emesis

M Goddard¹

Affiliations

PMID: 8398320
DOI: 10.1016/0959-8049(93)90369-q

Comment

The real costs of emesis

M Goddard. Eur J Cancer. 1993.

. 1993;29A(3):297-8.

doi: 10.1016/0959-8049(93)90369-q.

Author

M Goddard¹

Affiliation

¹ Centre for Health Economics, University of York.

PMID: 8398320
DOI: 10.1016/0959-8049(93)90369-q

No abstract available

PubMed Disclaimer

Comment on

The real costs of emesis--an economic analysis of ondansetron vs. metoclopramide in controlling emesis in patients receiving chemotherapy for cancer.
Cunningham D, Gore M, Davidson N, Miocevich M, Manchanda M, Wells N. Cunningham D, et al. Eur J Cancer. 1993;29A(3):303-6. doi: 10.1016/0959-8049(93)90372-m. Eur J Cancer. 1993. PMID: 8398322 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The real costs of emesis

Affiliation

The real costs of emesis

Author

Affiliation

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources